Search for: "MATTER OF B B J B" Results 4101 - 4120 of 5,814
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
19 Sep 2011, 9:36 am by Schachtman
With the exception of a few evidence scholars, Federal Rule of Evidence 703 is ignored or misunderstood in practice. [read post]
19 Sep 2011, 1:22 am by Adam Wagner
Perhaps the answer is that they should wait for the Crown to request an injunction to prevent publication, and then argue the matter there. [read post]
18 Sep 2011, 8:21 pm by Ken
Note than many of them, as in San Bernardino, are small claims matters. [read post]
17 Sep 2011, 2:54 pm by Michael Stevens
Therein, the Court described jurisdiction as follows: “[j]urisdiction, broadly defined, is the power of the court to decide an issue in controversy. [read post]
17 Sep 2011, 2:54 pm by Michael Stevens
Therein, the Court described jurisdiction as follows: “[j]urisdiction, broadly defined, is the power of the court to decide an issue in controversy. [read post]
16 Sep 2011, 2:33 am by war
Rares J made timetabling orders for defences (and cross-claims) and evidence with the trial fixed for 19 December 2011. [read post]
15 Sep 2011, 5:02 pm by Brad Pauley
McColm, S195379—Review Denied [Kennard, J., voting for review]—September 14, 2011 The pro per appellant had been previously adjudged a vexatious litigant. [read post]
13 Sep 2011, 9:50 am by Bill Callison
         In my prior article, Why a Fiduciary Duty Shift to Creditors of Insolvent Business Entities is Incorrect as a Matter of Theory and Practice, 1 J. [read post]
12 Sep 2011, 11:53 am
The power and jurisdiction of the court to issue appropriate warrant against an accused on his failure to attend the court on the date of hearing of the matter cannot be disputed. [read post]
12 Sep 2011, 3:15 am by Ben Vernia
Today’s announcement was made by Tony West, Assistant Attorney General of the Civil Division of the Department of Justice; J. [read post]
10 Sep 2011, 9:24 am by lawmrh
” This is why the news about what Idaho criminal defense lawyer Eric J. [read post]
6 Sep 2011, 4:00 pm by FDABlog HPM
  But even if so, FDA cannot make the same case for § 505(b)(2) drugs because the elements of a TE evaluation cannot be found in § 505(b)(2) (or any other statutory provision applicable to § 505(b)(2) drugs). [read post]